About
Technology
Issues
FAQ
Links
Official Page
The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.